| Our product range offers treatments in many areas of medical need. Our most important medicines in the UK, in terms of value, sales volume and future growth, are listed below.
You can find out detailed information on each product by going to information for patients and patient groups.
| Product name |
Disease area |
UK launch |
| Plavix® (clopidogrel) |
Cardiovascular disease |
September 1998 |
| Sustiva® (efavirenz) |
Anti-infective |
May 1999 |
| Aprovel® (irbesartan) |
Cardiovascular disease |
September 1997 |
| Reyataz® (atazanavir) |
Anti-infective |
March 2004 |
| Abilify® (aripiprazole) |
Central nervous system |
June 2004 |
| Perfalgan® (intravenous paracetamol) |
Analgesia |
April 2004 |
| Baraclude®
(entecavir) |
Anti-infective |
September 2006 |
| Sprycel® (dasatinib) |
Cancer |
December 2006 |
|
